We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Influence of -55CT Polymorphism of UCP3 Gene on Surgical Results of Biliopancreatic Diversion.
- Authors
De Luis, D. A.; Pacheco, D.; Aller, R.; Sagrado, M. González; Izaola, O.; Terroba, M. C.; Cuellar, L.; Conde, R.; Martin, T.; Castrillon, J. L. Perez
- Abstract
Bariatric surgery is the most effective long-term treatment for morbid obesity, reducing obesity-associated comorbidities. The purpose of the present study was to evaluate the UCP3 promotor (-55C→T) polymorphism outcomes 1 year after biliopancreatic diversion in morbidly obese patients. A sample of 40 morbidly obese patients (BMI >40 kg/m2) were operated. Weight, fat mass, blood pressure, basal glucose, triacylglycerols, total cholesterol, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol were measured at basal visit and at each visit. The frequency of patients with diabetes mellitus, hypertension, and hyperlipidemia was recorded at each visit. Twenty-eight patients (70%) had the genotype C/C (wild group) and 12 (30%) patients C/T (mutant group). In wild type group, body mass index, weight, fat mass, systolic blood pressure, glucose, total cholesterol, low-density lipoprotein cholesterol, and triacylglycerols concentrations decreased. In mutant type group, the same parameters improved, without statistical differences with wild group. Initial weight percent loss at 1 year of follow-up was similar in both genotypes (34.1% vs 28.6%; ns). Polymorphism -55C/T of the UCP3 promotor did not have an effect on weight loss or clinical outcomes after bariatric surgery.
- Subjects
BARIATRIC surgery; GENETIC polymorphisms; OVERWEIGHT persons; HIGH density lipoproteins; DIABETES
- Publication
Obesity Surgery, 2010, Vol 20, Issue 7, p895
- ISSN
0960-8923
- Publication type
Article
- DOI
10.1007/s11695-008-9510-2